Partnership brings important diabetes conversation to one of the world’s biggest stages Ad raises awareness of Dexcom continuous glucose monitoring as newer, better technology replacing painful fingerpricks In the face of a socially distanced Super Bowl Sunday, Dexcom is also giving fans the

SAN DIEGO --(BUSINESS WIRE)--Jan. 19, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, February 11, 2020 . Management will hold a conference call to review the company's fourth quarter

SAN DIEGO --(BUSINESS WIRE)--Jan. 11, 2021-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2020 to meet or exceed $567 million , an increase of 23% over the

SAN DIEGO --(BUSINESS WIRE)--Jan. 5, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer , Chairman, President and Chief Executive Officer, will present an update on the company at the 39 th annual J.P. Morgan Healthcare Conference on January 11, 2021 .